Biocodex is a family-owned French multinational pharmaceutical company founded in 1953, focused on microbiota care, women's health, and orphan diseases. Since 2016 it has invested in biotech startups developing innovative therapeutics, becoming a key player in the French biotech ecosystem.
Their most common stage is series-b (40% of deals).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EExeliom Biosciences | Series A | — | Jul 2023 |
| MMaat Pharma | Series B | — | Feb 2020 |
 Maat Pharma | Series B | — | Feb 2020 |
| NNextbiotix | Series A | — | Jul 2018 |
| EExeliom Biosciences | Seed | — | — |
Top Co-Investors
Seventure Partners2 shared
SymBiosis2 shared
French Tech Seed Fund1 shared
Crescent Capital Group1 shared
UI Investissement1 shared
Last updated: 14 September 2026